Announcements

The latest Impact Factors have been released and are updated in our site!

Not a Current Subscriber?

Subscribe Now

5642 Journals

4484 Congresses

10100+ Unique Records

Current Pharmaceutical Biotechnology

Title Abbreviation

Curr Pharm Biotechnol

ISSN

1389-2010

Electronic ISSN

1873-4316

Therapeutic Area

Biotechnology, Chemistry, Immunology, Molecular Medicine, Pharmacology

Readership

Bioengineers, Biologists, Molecular Biologists, Pharmacologists

Scope

Current Pharmaceutical Biotechnology aims to cover all the latest and outstanding developments in Pharmaceutical Biotechnology. Each issue of the journal includes timely in-depth/mini reviews, original research articles and letters written by leaders in the field, covering a range of current topics in scientific areas of Pharmaceutical Biotechnology. Invited and unsolicited review articles are welcome. The journal encourages contributions describing research at the interface of drug discovery and pharmacological applications, involving in vitro investigations and pre-clinical or clinical studies. Scientific areas within the scope of the journal include pharmaceutical chemistry, biochemistry and genetics, molecular and cellular biology, and polymer and materials sciences as they relate to pharmaceutical science and biotechnology. In addition, the journal also considers comprehensive studies and research advances pertaining food chemistry with pharmaceutical implication. Areas of interest include: DNA/protein engineering and processing; Synthetic biotechnology; Omics (genomics, proteomics, metabolomics and systems biology); Therapeutic biotechnology (gene therapy, peptide inhibitors, enzymes); Drug delivery and targeting; Nanobiotechnology; Molecular pharmaceutics and molecular pharmacology; Analytical biotechnology (biosensing, advanced technology for detection of bioanalytes); Pharmacokinetics and pharmacodynamics; Applied Microbiology; Bioinformatics (computational biopharmaceutics and modeling); Environmental biotechnology; Regenerative medicine (stem cells, tissue engineering and biomaterials); Translational immunology (cell therapies, antibody engineering, xenotransplantation); Industrial bioprocesses for drug production and development; Biosafety; Biotech ethics. Special Issues devoted to crucial topics, providing the latest comprehensive information on cutting-edge areas of research and technological advances, are welcome. Current Pharmaceutical Biotechnology is an essential journal for academic, clinical, government and pharmaceutical scientists who wish to be kept informed and up-to-date with the latest and most important developments.

Sponsoring Association(s)

No associations affiliated with this journal

Publisher Name

Bentham Science Publishers Ltd.

To see more details about Current Pharmaceutical Biotechnology, Subscribe Now!

Impact Factor JCR Categories/Rank Circulation Submission to Acceptance Acceptance to Online Publication Acceptance to Print Publication Rejection Rate Frequency Journal Contact Author Submission Guidelines

Testimonials

"PubsHub [Journals & Congresses] is an indispensable tool when trying to find the perfect home for a manuscript. It is an unbeatable aid when it comes to wise and efficient journal selection."
	– Kait G Editorial-Project Editor
"It’s useful for establishing publication timelines, communicating them to management and setting expectations accordingly"
	– Michael K. Medical Communications Leader
"…a gold mine of information for clinicians and scientists who are trying to determine where to publish their research."
	- Weill Cornell Medical Library

Journals ● Congresses ● Associations

Privacy Policy ● Terms of Service ● Glossary ● OSS ● Contact Us